Moreover, DET has been verified to suppress the abnormal activation of the NF-κB signaling pathway, which plays a critical role in the occurrence and treatment of pancreatic cancer by promoting proliferation, metastasis and GEM chemoresistance and inhibiting apoptosis. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.